Ligand Pharmaceuticals | LGND - Market Capitalization


Ligand Pharmaceuticals reported $3.52B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 184.41B 32.48B Feb/2026
Arrowhead Research USD 4.77B 2.59B Sep/2025
Baxter International USD 11.7B 3.84B Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Eli Lilly USD 1.02T 300.22B Feb/2026
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 86.59B 22.54B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Insmed USD 30.44B 11.35B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Ligand Pharmaceuticals USD 3.42B 1.23B Sep/2025
MacroGenics USD 114M 8M Feb/2026
Merck USD 293.38B 83.74B Feb/2026
Pacira USD 1.16B 51M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Veracyte USD 2.7B 584M Sep/2025